348 related articles for article (PubMed ID: 16777679)
1. Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies.
Smith MW; Gumbleton M
J Drug Target; 2006 May; 14(4):191-214. PubMed ID: 16777679
[TBL] [Abstract][Full Text] [Related]
2. Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.
Vlieghe P; Khrestchatisky M
Med Res Rev; 2013 May; 33(3):457-516. PubMed ID: 22434495
[TBL] [Abstract][Full Text] [Related]
3. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
[TBL] [Abstract][Full Text] [Related]
4. [Research advances in brain-targeted nanoscale drug delivery system].
Liu Y; Jiang C
Yao Xue Xue Bao; 2013 Oct; 48(10):1532-43. PubMed ID: 24417079
[TBL] [Abstract][Full Text] [Related]
5. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair.
Sharma A; Menon P; Muresanu DF; Ozkizilcik A; Tian ZR; Lafuente JV; Sharma HS
CNS Neurol Disord Drug Targets; 2016; 15(9):1092-1117. PubMed ID: 27538949
[TBL] [Abstract][Full Text] [Related]
6. Nano-enabled delivery systems across the blood-brain barrier.
Hwang SR; Kim K
Arch Pharm Res; 2014 Jan; 37(1):24-30. PubMed ID: 24170511
[TBL] [Abstract][Full Text] [Related]
7. The blood-brain barrier: clinical implications for drug delivery to the brain.
De Boer AG; Breimer DD
J R Coll Physicians Lond; 1994; 28(6):502-6. PubMed ID: 7884704
[TBL] [Abstract][Full Text] [Related]
8. Differential receptor-mediated drug targeting to the diseased brain.
Rip J; Schenk GJ; de Boer AG
Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
[TBL] [Abstract][Full Text] [Related]
9. From naturally-occurring neurotoxic agents to CNS shuttles for drug delivery.
Soddu E; Rassu G; Giunchedi P; Sarmento B; Gavini E
Eur J Pharm Sci; 2015 Jul; 74():63-76. PubMed ID: 25892455
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of nano-therapeutics for major disorders of the central nervous system.
Gao H; Pang Z; Jiang X
Pharm Res; 2013 Oct; 30(10):2485-98. PubMed ID: 23797465
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles and the blood-brain barrier: advancing from in-vitro models towards therapeutic significance.
Mc Carthy DJ; Malhotra M; O'Mahony AM; Cryan JF; O'Driscoll CM
Pharm Res; 2015 Apr; 32(4):1161-85. PubMed ID: 25446769
[TBL] [Abstract][Full Text] [Related]
12. Drug targeting to the brain.
de Boer AG; Gaillard PJ
Annu Rev Pharmacol Toxicol; 2007; 47():323-55. PubMed ID: 16961459
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnological advances for the delivery of CNS therapeutics.
Wong HL; Wu XY; Bendayan R
Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
[TBL] [Abstract][Full Text] [Related]
14. Targeting central nervous system pathologies with nanomedicines.
Mizrahy S; Gutkin A; Decuzzi P; Peer D
J Drug Target; 2019; 27(5-6):542-554. PubMed ID: 30296187
[TBL] [Abstract][Full Text] [Related]
15. Current advances in delivery of biotherapeutics across the blood-brain barrier.
Rajadhyaksha M; Boyden T; Liras J; El-Kattan A; Brodfuehrer J
Curr Drug Discov Technol; 2011 Jun; 8(2):87-101. PubMed ID: 21513485
[TBL] [Abstract][Full Text] [Related]
16. Selective drug delivery approaches to lesioned brain through blood brain barrier disruption.
Al-Ahmady ZS
Expert Opin Drug Deliv; 2018 Apr; 15(4):335-349. PubMed ID: 29466890
[TBL] [Abstract][Full Text] [Related]
17. From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery.
Banks WA
Nat Rev Drug Discov; 2016 Apr; 15(4):275-92. PubMed ID: 26794270
[TBL] [Abstract][Full Text] [Related]
18. Vector-mediated drug delivery to the brain.
Temsamani J; Rousselle C; Rees AR; Scherrmann JM
Expert Opin Biol Ther; 2001 Sep; 1(5):773-82. PubMed ID: 11728213
[TBL] [Abstract][Full Text] [Related]
19. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
Begley DJ
Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
[TBL] [Abstract][Full Text] [Related]
20. Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.
Patel MM; Patel BM
CNS Drugs; 2017 Feb; 31(2):109-133. PubMed ID: 28101766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]